Malaria Vaccine Passes First Clinical Tests
During tests of a new malaria vaccine, intravenous delivery and use of radiation-weakened parasites proved effective at preventing the disease in small groups of adults. Scientists irradiated billions of malaria parasites in lab-raised mosquitos and used them to create the vaccine. The promising results encourage further efforts to test the vaccine’s long-term protection and develop accessible delivery options for malaria hotspots in remote areas.
Science Bulletins is a production of the National Center for Science Literacy, Education, and Technology (NCSLET), part of the Department of Education at the American Museum of Natural History.
RELATED LINKS
Science: Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine.
ncbi.nlm.nih.govSanaria: Malaria Eradication Through Vaccination
sanaria.comCenters for Disease Control and Prevention: Malaria
cdc.govNational Institutes of Health: Vaccine Research Center
niaid.nih.govWorld Health Organization: Malaria
who.int
.phone.jpg)
